Friday, December 15, 2017
8 updates on liver transplantation outcomes for 2017: Over the past year, researchers and physicians have reported changes among the leading indications on the liver waitlist and improvements in transplantation outcomes. In this article, Healio.com/Hepatology presents recent reports on waitlist mortality risks, improved pediatric liver transplantation outcomes, and the positive effects of HCV treatment on transplant and waitlist outcomes.
Liver Damage Worse in Women With HBV/HCV Coinfection, Risky Drinking: According to a recent study in PLoS One, coinfection with hepatitis B and C virus (HBV/HCV) combined with risky alcohol consumption enhances liver damage mechanisms to a greater extent in women than in men.
Liver cancer incidence after HCV therapy linked to risk factors, not treatment: For those of you who still think that DAA treatment for hepatitis C correlates with an increased risk for hepatocellular carcinoma, the verdict is in: The results from a large cohort study of both treated and untreated patients with or without cirrhosis showed that those with incident HCC after DAA treatment had higher risk factors at baseline, and that “there was no increased risk for HCC as a result of having received DAA therapy whatsoever.”
HepCBC is seeking an Operations Manager. The position is part-time/~20 hours per week (limited-time contract until July 2018). The deadline for applications is December 31, 2017. You can read the complete job description here.